Unlocking the potential of the gut microbiome

Understanding the role of the gut microbiome in cancer and how we can manipulate the microbiome to improve patient treatment response has the potential to decrease global cancer mortality and suffering.

Unlocking the potential of the gut microbiome

Understanding the role of the gut microbiome in cancer and how we can manipulate the microbiome to improve patient treatment response has the potential to decrease global cancer mortality and suffering.

Persephone’s approach

Persephone is poised to unlock the potential of the gut microbiome for the development of precision medicine by the implementation of population-scale clinical trials, advanced genomics and immunology techniques, and machine learning. Through what we believe to be one of the largest clinical study programs ever pursued in the gut microbiome space, Persephone is creating vast datasets to develop evidence-based biomarkers supporting our precision medicines.

Persephone’s approach

Persephone is poised to unlock the potential of the gut microbiome for the development of precision medicine by the implementation of population-scale clinical trials, advanced genomics and immunology techniques, and machine learning.

Through what we believe to be one of the largest clinical study programs ever pursued in the gut microbiome space, Persephone is creating vast datasets to develop evidence-based biomarkers supporting our precision medicines.

Real-world patient data

We conduct population-scale clinical studies to enable equitable precision medicines. To do this, we created an infrastructure of clinical sites nationwide to acquire patient medical data and collect stool (gut microbiome) and blood (immune) samples from thousands of healthy and cancer patients nationwide.

We have also solved an industry wide problem of stool collection with the development of a proprietary easy-to-use stool collection kit.

Real-world patient data

We conduct population-scale clinical studies to enable equitable precision medicines. To do this, we created an infrastructure of clinical sites nationwide to acquire patient medical data and collect stool (gut microbiome) and blood (immune) samples from thousands of healthy and cancer patients nationwide.

We have also solved an industry wide problem of stool collection with the development of a proprietary easy-to-use stool collection kit.

Clinical Studies

Cutting-edge multi-omics analyses map gut-immune axis

Our groundbreaking multi-omics platform decodes the gut-immune axis to establish a new paradigm in precision medicine. We analyze DNA, RNA, metabolite, and protein data from multi-omics analyses on patient stool and blood samples to discover cancer biomarkers.

Cutting-edge multi-omics analyses map gut-immune axis

Our groundbreaking multi-omics platform decodes the gut-immune axis to establish a new paradigm in precision medicine. We analyze DNA, RNA, metabolite, and protein data from multi-omics analyses on patient stool and blood samples to discover cancer biomarkers.

Augmented intelligence (AI) decodes novel biology

We use augmented intelligence, a combination of artificial and human intelligence to train on data from thousands of cancer stool and blood samples to identify evidence-based biomarkers.

Training on healthy samples allows us to determine what normal gut-immune biomarkers should look like.

Augmented intelligence (AI) decodes novel biology

We use augmented intelligence, a combination of artificial and human intelligence to train on data from thousands of cancer stool and blood samples to identify evidence-based biomarkers.

Training on healthy samples allows us to determine what normal gut-immune biomarkers should look like.

Evidence-based biomarkers lead to actionable insights

Augmented intelligence identifies biomarker patterns that predict:

  • Effective treatments for patients.

 

  • Cancer markers for early detection.

 

  • Novel biology for the development of next generation precision therapies.
  1.  

Evidence-based biomarkers lead to actionable insights

Augmented intelligence identifies biomarker patterns that predict:

  • Effective treatments for patients.

 

  • Cancer markers for early detection.

 

  • Novel biology for the development of next generation precision therapies.
  1.